Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.

Journal of endocrinological investigation2026PMID: 42002673

View on PubMed DOI: 10.1007/s40618-026-02895-3

Authors

Galindo, Rodolfo J; Aronne, Louis J; Horn, Deborah B; Miras, Alexander D; Dunn, Julia P; Cao, Dachuang; Lee, Clare J; Karanikas, Chrisanthi A; Heine, Robert J; Falcon, Beverly L; Dimitriadis, Georgios K

Keywords

Clinical trialObesityPost hoc analysisPrediabetesSURMOUNT-5SemaglutideTirzepatide